Targeting EGFR and WNTand#946; catenin pathway to monitor and sensitize CSC mediated therapy resistance in Head and Neck Cancer

dc.contributor.guide	Banerjee, B.
dc.coverage.spatial	Biotechnology
dc.creator.researcher	Roy, S.
dc.date.accessioned	2022-01-19T11:01:26Z
dc.date.available	2022-01-19T11:01:26Z
dc.date.awarded
dc.date.completed	2020
dc.date.registered
dc.description.abstract	Abstract is available newline
dc.description.note	Bibliography p.142-166
dc.format.accompanyingmaterial	None
dc.format.dimensions
dc.format.extent	193p.
dc.identifier.uri	http://hdl.handle.net/10603/356935
dc.language	English
dc.publisher.institution	School of Biotechnology
dc.publisher.place	Bhubaneswar
dc.publisher.university	KIIT University
dc.relation	No. of reference 273
dc.rights	university
dc.source.university	University
dc.subject.keyword	Biology and Biochemistry
dc.subject.keyword	Developmental Biology
dc.subject.keyword	Life Sciences
dc.title	Targeting EGFR and WNTand#946; catenin pathway to monitor and sensitize CSC mediated therapy resistance in Head and Neck Cancer
dc.title.alternative
dc.type.degree	Ph.D.